Published in Nat Biotechnol on April 01, 1998
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol (2010) 7.90
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol (2001) 4.89
Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol (2010) 4.18
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother (2000) 3.56
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol (2011) 3.25
Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc Natl Acad Sci U S A (1999) 3.10
DNA probes using fluorescence resonance energy transfer (FRET): designs and applications. Biotechniques (2001) 3.08
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
From genes to machines: DNA nanomechanical devices. Trends Biochem Sci (2005) 2.29
Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol (2001) 2.21
Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother (2005) 2.17
Demonstration of preferential binding of SYBR Green I to specific DNA fragments in real-time multiplex PCR. Nucleic Acids Res (2003) 2.01
Hybridization kinetics and thermodynamics of molecular beacons. Nucleic Acids Res (2003) 1.88
Molecular engineering of DNA: molecular beacons. Angew Chem Int Ed Engl (2009) 1.84
Using molecular beacons as a sensitive fluorescence assay for enzymatic cleavage of single-stranded DNA. Nucleic Acids Res (2000) 1.78
A new class of homogeneous nucleic acid probes based on specific displacement hybridization. Nucleic Acids Res (2002) 1.76
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother (2008) 1.75
Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J Clin Microbiol (2004) 1.73
Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial. J Clin Microbiol (2011) 1.69
Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol (2004) 1.66
Genetic methods for assessing antimicrobial resistance. Antimicrob Agents Chemother (1999) 1.60
Fluorescent probes for live-cell RNA detection. Annu Rev Biomed Eng (2009) 1.59
Comparison of real-time, quantitative PCR with molecular beacons to nested PCR and culture methods for detection of Mycobacterium avium subsp. paratuberculosis in bovine fecal samples. J Clin Microbiol (2002) 1.53
Hairpin primers for simplified single-nucleotide polymorphism analysis of Mycobacterium tuberculosis and other organisms. J Clin Microbiol (2004) 1.48
Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res (2011) 1.46
Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.43
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics. Proc Natl Acad Sci U S A (2001) 1.41
Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol (2004) 1.41
Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol (2006) 1.38
Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. J Clin Microbiol (2003) 1.37
Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol (2000) 1.34
Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes. Am J Pathol (1998) 1.30
Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay. J Clin Microbiol (2001) 1.27
Quantification of CCR5 mRNA in human lymphocytes and macrophages by real-time reverse transcriptase PCR assay. Clin Diagn Lab Immunol (2003) 1.21
A dual-tag microarray platform for high-performance nucleic acid and protein analyses. Nucleic Acids Res (2008) 1.20
Label-free hybridization detection of a single nucleotide mismatch by immobilization of molecular beacons on an agarose film. Nucleic Acids Res (2002) 1.18
PCR hot start using primers with the structure of molecular beacons (hairpin-like structure). Nucleic Acids Res (2000) 1.12
Simultaneous identification of Mycobacterium genus and Mycobacterium tuberculosis complex in clinical samples by 5'-exonuclease fluorogenic PCR. J Clin Microbiol (2002) 1.08
Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv (2013) 1.06
Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrob Agents Chemother (2000) 1.04
Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California. J Clin Microbiol (2010) 1.03
Rapid, sensitive, and discriminating identification of Naegleria spp. by real-time PCR and melting-curve analysis. Appl Environ Microbiol (2006) 1.00
Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system. J Clin Microbiol (2002) 0.98
Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography. J Clin Microbiol (2004) 0.97
Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assay. Clin Diagn Lab Immunol (2002) 0.96
Enzymatic signal amplification of molecular beacons for sensitive DNA detection. Nucleic Acids Res (2008) 0.96
Conditionally fluorescent molecular probes for detecting single base changes in double-stranded DNA. Nat Chem (2013) 0.95
Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology. J Clin Microbiol (2009) 0.95
Reporter phage and breath tests: emerging phenotypic assays for diagnosing active tuberculosis, antibiotic resistance, and treatment efficacy. J Infect Dis (2011) 0.91
Visual format for detection of Mycobacterium tuberculosis and M. bovis in clinical samples using molecular beacons. J Mol Diagn (2009) 0.91
In vitro selection of molecular beacons. Nucleic Acids Res (2003) 0.90
Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing. Am J Med Sci (2013) 0.90
Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis. PLoS One (2016) 0.90
Visualization and detection of infectious coxsackievirus replication using a combined cell culture-molecular beacon assay. Appl Environ Microbiol (2005) 0.87
Genotyping of single nucleotide polymorphisms by 5' nuclease allelic discrimination. Methods Mol Biol (2012) 0.87
Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound. Ann Am Thorac Soc (2014) 0.85
Immobilized stem-loop structured probes as conformational switches for enzymatic detection of microbial 16S rRNA. Nucleic Acids Res (2005) 0.85
A new approach to SNP genotyping with fluorescently labeled mononucleotides. Nucleic Acids Res (2004) 0.85
Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus. J Clin Microbiol (2003) 0.84
Tripartite molecular beacons. Nucleic Acids Res (2002) 0.84
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clin Microbiol Rev (2016) 0.84
Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by use of an asymmetrically split peroxidase DNAzyme. J Clin Microbiol (2012) 0.83
A FRET-based analysis of SNPs without fluorescent probes. Nucleic Acids Res (2004) 0.82
Molecular beacons in diagnostics. F1000 Med Rep (2012) 0.82
Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR. Mem Inst Oswaldo Cruz (2012) 0.81
Detection of acid-fast bacilli in postlysis debris of clinical specimens improves the reliability of PCR. J Clin Microbiol (2005) 0.81
Methods for strand-specific DNA detection with cationic conjugated polymers suitable for incorporation into DNA chips and microarrays. Proc Natl Acad Sci U S A (2005) 0.80
Fluorescent probes for the analysis of DNA strand scission in base excision repair. Nucleic Acids Res (2010) 0.80
Rapid detection of a molecular marker for chloroquine-resistant falciparum malaria. Antimicrob Agents Chemother (2002) 0.80
PrP genotype frequencies of Quebec sheep breeds determined by real-time PCR and molecular beacons. Can J Vet Res (2008) 0.80
NANOSTRUCTURED PROBES FOR IN VIVO GENE DETECTION. Nanomedicine (Chichester) (2010) 0.78
A highly fluorescent DNA toolkit: synthesis and properties of oligonucleotides containing new Cy3, Cy5 and Cy3B monomers. Nucleic Acids Res (2012) 0.78
Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria. Diagn Microbiol Infect Dis (2010) 0.78
Application of a molecular beacon based real-time isothermal amplification (MBRTIA) technology for simultaneous detection of Bacillus cereus and Staphylococcus aureus. J Food Sci Technol (2014) 0.78
Current tuberculosis diagnostic tools & role of urease breath test. Indian J Med Res (2012) 0.78
Using force spectroscopy analysis to improve the properties of the hairpin probe. Nucleic Acids Res (2007) 0.77
Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR. PLoS One (2017) 0.75
Rifoligotyping assay: an alternative method for rapid detection of rifampicin resistance in Mycobacterium tuberculosis isolates from Morocco. Biotechnol Biotechnol Equip (2014) 0.75
Detecting drug-resistant tuberculosis: beacons in the dark. Nat Biotechnol (1998) 0.75
Multiplexed fluorescence readout using time responses of color coded signals for biomolecular detection. Biomed Opt Express (2016) 0.75
Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol (1996) 21.49
Multicolor molecular beacons for allele discrimination. Nat Biotechnol (1998) 9.40
Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol (2002) 8.88
Structure-independent nucleotide sequence analysis. Proc Natl Acad Sci U S A (1979) 8.65
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother (1994) 6.39
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS (2001) 5.52
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet (1993) 4.96
Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol (2001) 4.89
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci U S A (1999) 4.46
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA (1996) 4.38
Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol (1999) 4.27
Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med (1995) 4.10
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother (2000) 3.56
Autocatalytic replication of a recombinant RNA. J Mol Biol (1983) 3.55
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J Clin Microbiol (1995) 3.20
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation (1999) 3.16
Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 3.15
Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc Natl Acad Sci U S A (1999) 3.10
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother (1997) 3.05
Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal (1999) 2.99
Spectral genotyping of human alleles. Science (1998) 2.95
RNA sequencing with radioactive chain-terminating ribonucleotides. Proc Natl Acad Sci U S A (1978) 2.67
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66
Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural basis of protein splicing. Nat Struct Biol (1998) 2.59
Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis (1995) 2.59
Molecular beacon probes combined with amplification by NASBA enable homogeneous, real-time detection of RNA. Nucleic Acids Res (1998) 2.53
Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother (1997) 2.53
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clin Pharmacol Ther (2007) 2.48
HIV treatment failure: testing for HIV resistance in clinical practice. Science (1998) 2.46
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol (1997) 2.24
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J Antimicrob Chemother (1995) 2.22
Novel, ligation-dependent PCR assay for detection of hepatitis C in serum. J Clin Microbiol (1996) 2.19
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17
A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis (1997) 2.14
Template-determined, variable rate of RNA chain elongation. Cell (1978) 2.02
Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother (1999) 2.02
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 1.94
A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med (1992) 1.93
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem (2000) 1.92
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model. Antimicrob Agents Chemother (2008) 1.89
Transcription from bacteriophage T7 and SP6 RNA polymerase promoters in the presence of 3'-deoxyribonucleoside 5'-triphosphate chain terminators. Biochemistry (1985) 1.88
Wavelength-shifting molecular beacons. Nat Biotechnol (2000) 1.87
The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem (2001) 1.82
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Res Hum Retroviruses (2000) 1.82
Complete nucleotide sequence of a replicating RNA molecule. Science (1973) 1.78
Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis (2000) 1.77
The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun (2001) 1.73
CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet (1998) 1.62
Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J Clin Microbiol (1997) 1.59
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther (2009) 1.57
Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy. AIDS (2001) 1.55
A replicating RNA molecule suitable for a detailed analysis of extracellular evolution and replication. Proc Natl Acad Sci U S A (1972) 1.55
Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye (Lond) (1996) 1.54
Changing trends in acute poisoning in Chandigarh zone: a 25-year autopsy experience from a tertiary care hospital in northern India. Am J Forensic Med Pathol (1999) 1.51
Evaluation of the relatedness of strains of Mycobacterium avium using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis (1995) 1.51
Evolution in vitro: sequence and phenotype of a mutant RNA resistant to ethidium bromide. J Mol Biol (1974) 1.51
Genotypic characterization of Mycobacterium avium strains recovered from animals and their comparison to human strains. Appl Environ Microbiol (1995) 1.47
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG. Infect Immun (2004) 1.44
Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.43
Epidemiologic programs for computers and calculators. Exact binomial confidence intervals for the relative risk in follow-up studies with sparsely stratified incidence density data. Am J Epidemiol (1987) 1.38
Molecular beacons: a new approach for semiautomated mutation analysis. Clin Chem (1998) 1.37
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (1999) 1.36
The ontogeny of excitatory amino acid receptors in rat forebrain--I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience (1990) 1.34
Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol (2000) 1.34
Secondary structure formation during RNA synthesis. Nucleic Acids Res (1981) 1.33
Genomic function during the lampbrush chromosome stage of amphibian oogenesis. Proc Natl Acad Sci U S A (1966) 1.28
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol (2001) 1.22
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20
Terminal adenylation in the synthesis of RNA by Q beta replicase. J Biol Chem (1983) 1.18
Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare. J Antimicrob Chemother (1994) 1.16
Extremely sensitive, background-free gene detection using binary probes and beta replicase. Proc Natl Acad Sci U S A (1996) 1.15
Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: a countrywide 9-year cohort study. Swiss HIV Cohort Study. Infection (2000) 1.14
The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc Natl Acad Sci U S A (2009) 1.13
The decaying genome of Mycobacterium leprae. Lepr Rev (2001) 1.11
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.10
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry (2001) 1.08
Quantitative assays based on the use of replicatable hybridization probes. Clin Chem (1989) 1.06
Encounters with pseudoaneurysms in orthopaedic practice. Injury (2001) 1.06